LONDON, Feb. 6, 2025 — Inizio, a commercialization partner for health and life science companies, has appointed Colin Stanley as Chief Commercial Officer (CCO), Remco op den Kelder as President of Inizio Advisory, and Jim Sage as President of Inizio Engage.

Mr. Stanley brings over 25 years of industry experience in business growth, commercialization, and CRO roles to his new position.

“Colin has significantly contributed to our enterprise commercial model and its success with pharma clients,” said Paul Taaffe, Inizio’s CEO. “We’re expanding this model to assist clients at every stage, from discovery to post-launch.”

Mr. Stanley transitions from President of Inizio Advisory, a role now filled by Mr. op den Kelder, who previously led Putnam, an Inizio Advisory company.

Mr. op den Kelder oversaw Putnam’s substantial growth and established its strong client reputation. He will focus on continued innovation within Inizio Advisory.

Mr. Sage, Inizio Engage’s new President, brings over 25 years of experience in successfully commercializing blockbuster brands at Pfizer. His experience includes serving as North American Regional President for Pfizer’s Internal Medicine business and US Country Manager. He will continue to build on Inizio Engage’s success.

Mr. Taaffe stated, “Remco and Jim’s expertise will strengthen our reputation and empower our clients to deliver life-changing therapies.”

The previous President of Inizio Engage, Greg Flynn, will become a Senior Advisor to Inizio Engage and Chairman of Patient Access Services.

Mr. Taaffe expressed gratitude for Mr. Flynn’s 20 years of service, noting his contributions to Inizio Engage’s growth and his suitability for focusing on key growth areas.

Discover more about Inizio’s scaled commercialization platform

About Inizio

Inizio partners with health and life sciences companies, providing tailored solutions for clinical development and commercialization to maximize patient access. Its integrated capabilities guide clients through key lifecycle moments, simplifying processes, unlocking value, and improving treatment outcomes.

Inizio comprises five specialist business units, each offering comprehensive solutions for transforming healthcare.

Inizio is backed by CD&R. For more information visit:  

Media Contact
Daniel McIver: PR Manager
 

Photo –